Go to deals
Healthcare

ZoomMed Inc. has sold certain assets to TELUS Health

July 2014 — TELUS Health, Canada’s largest Electronic Medical Records (EMR) provider and a leader in the Canadian claims and benefits management sector, is adding important new functionality to its existing health technology portfolio through its acquisition of an interest in the underlying technology of the ZRx Prescriber from Quebec-based ZoomMed Inc. Financial details have not been disclosed.

ZoomMed Inc. is a publicly traded company (TSXV: ZMD) that builds and operates a clinical information exchange platform between physicians, pharmacists and the various other stakeholders of the Health sector with whom they interact. The company has the largest private network of electronic prescriptions and drug information system in Canada.

TELUS Health is a leader in telehomecare, electronic medical and health records, consumer health, benefits management and pharmacy management. TELUS Health solutions give health authorities, providers, physicians, patients and consumers the power to turn information into better health outcomes. It is an operating subsidiary of TELUS (TSX: T), one of Canada’s largest telecommunication companies.

“This acquisition builds upon our EMR leadership position and claims and benefits expertise, and allows us to have a more direct and positive impact on the patient experience, which ultimately leads to better health outcomes for Canadians,” said Paul Lepage, President of TELUS Health.

Our role in the transaction

Oaklins' team in Montreal advised the seller in this transaction.

Parties

Talk to the deal team

Sebastien Nadeau

Managing Partner
Montreal, Canada
Oaklins Canada

Fausto Levy

Principal
Montreal, Canada
Oaklins Canada

Related deals

UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more